The University of Chicago Header Logo

Connection

Olufunmilayo Olopade to Cetuximab

This is a "connection" page, showing publications Olufunmilayo Olopade has written about Cetuximab.
Connection Strength

0.031
  1. Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo. Target Oncol. 2015 Dec; 10(4):501-8.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.